Skip to content

    OSEL Devices

    OSELDEVICE
    Healthcare·2 Jun 2026
    Management Summary

    OSEL Devices reported a strong H2 FY26, with significant growth in revenue, EBITDA, and PAT, driven by all three business verticals. The company is strategically expanding its export capabilities with the upcoming JNPA SEZ hub and enhancing its hearing aid segment through the SFL retail acquisition for higher margins. However, the period saw a doubling of interest costs and some revenue deferrals due to logistics issues, alongside a reclassification of prior financial statements.

    Highlights

    5
    • Revenue grew 56.9% to ₹292.7 crores in H2 FY26, demonstrating strong top-line performance.

    • EBITDA expanded 57.9% to ₹53.3 crores, with margins at 18.2%, indicating operational efficiency.

    • Profit after tax increased 45.7% to ₹29.2 crores, reflecting healthy bottom-line growth.

    • All three verticals (LED display, hearing aids, mobile devices) contributed to the growth.

    • JNPA SEZ hub received LOI, with commercialization expected from April 2027, poised to boost exports and OEM capacity.

    Concerns

    3
    • Interest costs 'almost doubled' in H2 FY26 due to increased working capital limits and mutual fund-backed borrowings.

    • ₹25-30 crores of H2 FY26 revenue were delayed to April due to war-related logistics and supply chain disruptions.

    • Financial statements for FY25 were regrouped/reclassified, leading to questions about past reporting accuracy.

    Key financials

    Single quarter

    05 metrics
    1. 01Revenue₹292.7 Cr+56.9%YoY
    2. 02EBITDA₹53.3 Cr+57.9%YoY
    3. 03EBITDA Margin18.2%
    4. 04PAT₹29.2 Cr+45.7%YoY
    5. 05Export Revenue₹23 Cr

    Segment breakdown

    Hearing Aid
    42% Revenue Mix
    Mobile Devices
    4,50,000 Feature Phones Sold
    LED Display
    300 locations SaaS Platform Locations
    List

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    M&A

    SFL

    acquisition · integrated · Consideration ₹NaN (undisclosed)

    Liquidity

    Liquidity disclosed

    IPO funds were parked in mutual funds, and limits were taken against them, providing leverage for utilizing funds as required.

    Guidance & targets

    5
    CategoryTargetPriority
    Revenue
    FY27 Revenue Growth
    similar or even better than 56.9%
    Medium
    Profitability
    FY27 EBITDA Margins
    similar or even better than 18.2%
    Medium
    Commercialization
    JNPA SEZ Hub Commercialization
    April 2027
    High
    Volume
    LED SaaS Platform Units
    100,000 units
    Medium
    Sales
    FY27 Export Sales
    ₹50 crores
    Medium

    JNPA SEZ Capex & Timelines

    next quarter
    CurrentLOI received, capex numbers being finalized
    TargetSpecific capex amount and firm commercialization timeline

    Why it matters

    This project is key for future export and OEM capacity expansion and will impact capital allocation.

    Once we have the complete clarity on it, we will know the numbers that would be required for the capex in that.

    How to verify

    capital_allocation.capex.fy_planned

    Risks & concerns

    2
    RiskSeverity

    Logistics and supply chain disruptions

    War-related logistics delays and electronic supply chain disturbances caused ₹25-30 crores of H2 FY26 revenue to be pushed to April.Management acknowledged

    medium

    Increased interest costs

    Interest costs 'almost doubled' in H2 FY26 due to increased working capital limits and interest on mutual fund-backed borrowings.Management acknowledged

    medium

    Q&A highlights

    7

    “So, this came into our understanding as well, and I think in the current financials we have rectified this. And the new financials are based on these parameters only. ... we had to park the funds and we parked it into mutual funds. And then we have taken up limits against that mutual fund, which gives us the interest arbitrage anyway happening.”

    Addressed concerns about financial reporting accuracy and explained the strategy behind parking IPO funds in mutual funds and drawing limits against them.

    asked by Pratiti Khara

    3 min read7 chapters

    Detailed Narrative

    01

    Strong H2 FY26 Financial Performance

    OSEL Devices Limited delivered robust financial results for H2 FY26, with revenue growing 56.9% to ₹292.7 crores. EBITDA expanded by 57.9% to ₹53.3 crores, achieving a margin of 18.2%. Profit after tax also saw significant growth, increasing by 45.7% to ₹29.2 crores. This strong performance was broad-based, with all three key verticals—LED display, hearing aids, and mobile devices—contributing positively to the growth.

    02

    Strategic Expansion into High-Value Segments

    The company emphasizes its unique position with full ownership of the value chain, from R&D to clinic-led retail. OSEL holds critical certifications like US FDA, ISO 13485, and CDSCO MD5, which enable recurring revenue streams through its proprietary CMS platform and SFL clinic network. Management highlighted a strategic shift towards higher-value endpoints in each vertical, aiming to enhance both top-line growth and EBITDA margins over the next four to five years.

    03

    JNPA SEZ Hub to Drive Exports and OEM

    A significant future growth driver is the upcoming JNPA SEZ hub, expected to be commercialized from April 2027. This facility will substantially increase OSEL's export capabilities and OEM capacity, leveraging India's business port and SEZ tax benefits. The company aims to target international markets, particularly in North America, the Middle East, and Africa, with its LED products, capitalizing on the 'China plus one' manufacturing trend. The Letter of Intent (LOI) for the project has been received, and detailed capex figures are currently being worked out.

    04

    Hearing Aid Segment: Retail-Led Margin Expansion

    The acquisition of SFL, a network of audiologist clinics, is pivotal for OSEL's entry into the high-margin retail segment of hearing aids. While current sales to government segments yield lower margins (₹2,500-₹3,000 per unit), the retail model through SFL is expected to achieve significantly higher realizations (₹35,000-₹40,000 per unit). This shift is anticipated to substantially boost profitability, tapping into India's largely underserved hearing aid market, where penetration is currently less than 3%.

    05

    Growth in Mobile Devices Business

    OSEL, licensed to manufacture Philips-branded mobile phones, has successfully entered the smartphone market since March, building on its initial success with feature phones. In FY26, the company sold over 4.5 lakh feature phones. While manufacturing is currently outsourced, OSEL plans to establish its own manufacturing setup once sufficient scale is achieved. This segment is projected to experience significant growth in the coming year, contributing substantially to the company's top line.

    06

    Financial Reporting Adjustments and Interest Cost Dynamics

    The company reclassified short-term borrowings from operating to financing activities in its FY25 cash flow statement to correct prior erroneous reporting. Interest costs 'almost doubled' in H2 FY26, primarily due to increased working capital limits and interest incurred on IPO funds parked in mutual funds, against which credit limits were drawn. Management is working to improve working capital utilization and reduce interest terms through instruments like LCs.

    07

    Impact of Logistics Delays on H2 FY26 Revenue

    H2 FY26 revenue was negatively impacted by ₹25-30 crores due to logistics delays and electronic supply chain disturbances, partly attributed to geopolitical events. This deferred revenue, which would have been recognized in March, was pushed into April, contributing to a 'flattish' revenue performance in H2 compared to H1. The company expects to recover this in the subsequent period.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.